Pachymetry-guided keratoplasty useful for keratoconus

Article

Pachymetry-guided custom excimer laser–assisted lamellar keratoplasty is a useful surgical procedure for the treatment of moderate to advanced keratoconus.

Pachymetry-guided custom excimer laser–assisted lamellar keratoplasty is a useful surgical procedure for the treatment of moderate to advanced keratoconus.

The prospective noncomparative case series, led by Dr Leopoldo Spadea, Eye Clinic, University of L'Aquila, L'Aquila, Italy, examined 43 keratoconic eyes preoperatively and 3, 6, 12, and 24 months postoperatively. All patients underwent transepithelial excimer laser ablation.

The outcome measures were uncorrected (UDVA) and corrected (CDVA) distance visual acuities, manifest refraction, computerized videokeratography, pachymetry and endothelial specular microscopy.

Of the 43 eyes studied, 35 were included in the 24-month follow-up visit. UDVA was better than 20/60 in 16 patients and the CDVA was 20/40 or better in 31 patients. Mean refractive astigmatism was −2.11 D and mean spherical equivalent manifest refraction was -2.60 D.

The surgical procedure eradicates the need for an invasive procedure of penetrating keratoplasty.

The abstract can be found in the Journal of Cataract and Refractive Surgery.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
© 2025 MJH Life Sciences

All rights reserved.